サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424054

サイトメガロウイルス治療市場、シェア、市場規模、動向、産業分析レポート：薬剤別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Cytomegalovirus Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug (Ganciclovir, Valganciclovir, Cidofovir, Foscarnet, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
サイトメガロウイルス治療市場、シェア、市場規模、動向、産業分析レポート：薬剤別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、サイトメガロウイルス治療の世界市場規模は2032年までに10億3,516万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

革新的な治療アプローチがサイトメガロウイルス（CMV）治療市場の力強い成長を促進しています。抗ウイルス薬開発、免疫療法、標的治療における新たな戦略により、市場は変貌を遂げつつあります。養子T細胞移植や免疫調整剤は、CMV感染に対する免疫応答を高める可能性があるとして認知されつつあります。先進的な薬剤製剤や併用療法に関する継続的な調査により、より効果的で標的を絞った選択肢が生まれつつあります。CMV治療市場は、先進的で患者中心のソリューションに対する需要に適応しており、サイトメガロウイルス感染症に関連する複雑な問題に対処する上で、科学的進歩と治療イノベーションの相乗効果を示しています。

CMV感染症が公衆衛生に与える影響を認識し、各国政府は研究、診断、高度な治療ソリューションに積極的に資金を割り当てています。こうした戦略的な取り組みは、認知度の向上、早期発見の確保、最先端治療へのアクセスの促進に重点を置いています。特にガンシクロビルのような抗ウイルス薬の研究開発に対する財政支援は、CMV治療の水準を高めています。また、政府主導のプログラムは、社会的弱者における特定の課題を対象としており、CMV治療における協力的な進歩を促進し、より広範な世界的公衆衛生の目標に貢献しています。

核酸増幅アッセイや血清学的検査のような精密で迅速なツールは、早期かつ正確なCMV検出を可能にし、ガンシクロビルなどの治療への需要を促進しています。ポイントオブケア検査や高度な画像診断法は、診断能力をさらに向上させ、タイムリーなCMV同定のための新たな道を開く。先進的な診断法と治療法の相乗効果により、患者ケアは再構築され、個別化された治療アプローチが提供されます。技術的な進化が進むにつれ、CMV治療市場は成長機会が拡大し、患者の転帰を向上させる上で技術革新が重要な役割を果たすようになります。

個別化ヘルスケアへのシフトは、治療計画を個々のニーズに合わせて調整し、アドヒアランスを高め、CMV感染の複雑性に対処します。革新的な治療法は副作用の最小化と治療成績の改善を最優先し、患者に優しい投与法と併用療法はCMV治療の進化に貢献しています。患者中心の医療という動向とともに、この市場はサイトメガロウイルス感染症治療の進歩と最適化のために有望です。

サイトメガロウイルス治療市場レポートハイライト

2023年には、抗ウイルス効果、ウイルスの選択的標的化、臨床的有効性により、ガンシクロビルセグメントが大きな市場シェアを占めました。

2023年には、CMV再活性化リスクの上昇と全体的な転帰改善の必要性から、幹細胞移植分野が大きな市場シェアを占めました。

2023年、病院薬局セグメントは、患者の継続的な診断とモニタリング、ヘルスケアユニット内でのアクセスの容易さにより、大きな収益シェアを占めました。

2023年には、北米地域がCMV感染の流行と発生率、研究開発により世界市場を独占しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のサイトメガロウイルス治療市場の洞察

  • サイトメガロウイルス治療市場- 流通チャネルのスナップショット
  • サイトメガロウイルス治療市場力学
    • 促進要因と機会
      • サイトメガロウイルス感染症の発生率の増加により、製品需要が刺激されると予測されています
      • 移植活動の増加により、サイトメガロウイルス治療市場の成長が期待される
    • 抑制要因と課題
      • 高額な治療費が市場の成長を妨げる可能性がある
  • PESTEL分析
  • サイトメガロウイルス治療市場流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のサイトメガロウイルス治療市場、薬剤別

  • 主な調査結果
  • イントロダクション
  • ガンシクロビル
  • バルガンシクロビル
  • シドフォビル
  • フォスカーネット
  • その他

第6章 世界のサイトメガロウイルス治療市場、用途別

  • 主な調査結果
  • イントロダクション
  • 臓器移植
  • 幹細胞移植
  • 先天性CMV感染症
  • その他

第7章 世界のサイトメガロウイルス治療市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • その他

第8章 世界のサイトメガロウイルス治療市場、地域別

  • 主な調査結果
  • イントロダクション
    • サイトメガロウイルス治療市場評価、地域別、2019-2032年
  • サイトメガロウイルス治療市場-北米
    • 北米：サイトメガロウイルス治療市場、薬剤別、2019-2032年
    • 北米：サイトメガロウイルス治療市場、流通チャネル別、2019-2032年
    • 北米：サイトメガロウイルス治療市場、用途別、2019～2032年
    • サイトメガロウイルス治療市場-米国
    • サイトメガロウイルス治療市場- カナダ
  • サイトメガロウイルス治療市場- 欧州
    • 欧州：サイトメガロウイルス治療市場、薬剤別、2019～2032年
    • 欧州：サイトメガロウイルス治療市場、流通チャネル別、2019-2032
    • 欧州：サイトメガロウイルス治療市場、用途別、2019～2032年
    • サイトメガロウイルス治療市場- 英国
    • サイトメガロウイルス治療市場- フランス
    • サイトメガロウイルス治療市場- ドイツ
    • サイトメガロウイルス治療市場- イタリア
    • サイトメガロウイルス治療市場- スペイン
    • サイトメガロウイルス治療市場- オランダ
    • サイトメガロウイルス治療市場- ロシア
  • サイトメガロウイルス治療市場- アジア太平洋
    • アジア太平洋：サイトメガロウイルス治療市場、薬剤別、2019～2032年
    • アジア太平洋：サイトメガロウイルス治療市場、流通チャネル別、2019～2032年
    • アジア太平洋：サイトメガロウイルス治療市場、用途別、2019～2032年
    • サイトメガロウイルス治療市場- 中国
    • サイトメガロウイルス治療市場- インド
    • サイトメガロウイルス治療市場- マレーシア
    • サイトメガロウイルス治療市場- 日本
    • サイトメガロウイルス治療市場- インドネシア
    • サイトメガロウイルス治療市場- 韓国
  • サイトメガロウイルス治療市場-中東およびアフリカ
    • 中東およびアフリカ：サイトメガロウイルス治療市場、薬剤別、2019～2032年
    • 中東およびアフリカ：サイトメガロウイルス治療市場、流通チャネル別、2019～2032年
    • 中東およびアフリカ：サイトメガロウイルス治療市場、用途別、2019～2032年
    • サイトメガロウイルス治療市場- サウジアラビア
    • サイトメガロウイルス治療市場- アラブ首長国連邦
    • サイトメガロウイルス治療市場- イスラエル
    • サイトメガロウイルス治療市場- 南アフリカ
  • サイトメガロウイルス治療市場-ラテンアメリカ
    • ラテンアメリカ：サイトメガロウイルス治療市場、薬剤別、2019-2032年
    • ラテンアメリカ：サイトメガロウイルス治療市場、流通チャネル別、2019-2032
    • ラテンアメリカ：サイトメガロウイルス治療市場、用途別、2019～2032年
    • サイトメガロウイルス治療市場- メキシコ
    • サイトメガロウイルス治療市場- ブラジル
    • サイトメガロウイルス治療市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bayer AG
  • Bristol Myers Squibb
  • Chimerix
  • Clinigen Group
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi
  • Genentech, Inc.
  • Gilead Sciences, Inc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific
図表

List of Tables

  • Table 1 Global Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 2 Global Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Cytomegalovirus Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 6 North America: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 9 U.S.: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 12 Canada: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 15 Europe: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 18 UK: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 21 France: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 24 Germany: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 27 Italy: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 30 Spain: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 33 Netherlands: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 36 Russia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 42 China: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 45 India: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 48 Malaysia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 51 Japan: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 54 Indonesia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 57 South Korea: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 66 UAE: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 69 Israel: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 72 South Africa: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 75 Latin America: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 78 Mexico: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 81 Brazil: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • Table 84 Argentina: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Cytomegalovirus Treatment Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Cytomegalovirus Treatment Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Drug
  • Figure 9. Global Cytomegalovirus Treatment Market, by Drug, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Cytomegalovirus Treatment Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Cytomegalovirus Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Cytomegalovirus Treatment Market
目次
Product Code: PM4417

The global Cytomegalovirus Treatment market size is expected to reach USD 1,035.16 million by 2032, according to a new study by Polaris Market Research. The report "Cytomegalovirus Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug (Ganciclovir, Valganciclovir, Cidofovir, Foscarnet, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Innovative therapeutic approaches are propelling robust growth in the Cytomegalovirus (CMV) Treatment Market. The market is transforming with novel strategies in antiviral drug development, immunotherapies, and targeted treatments. Adoptive T-cell transfer and immune modulators are gaining recognition for their potential to boost immune responses against CMV infections. Ongoing research into advanced drug formulations and combination therapies is generating more effective and targeted options. The CMV treatment market is adapting to the demand for advanced and patient-centric solutions, showcasing the synergy between scientific advancements and therapeutic innovation in addressing complexities associated with cytomegalovirus infections.

Recognizing the public health impact of CMV infections, governments globally are actively allocating funds for research, diagnosis, and advanced treatment solutions. These strategic efforts focus on increasing awareness, ensuring early detection, and promoting accessibility to cutting-edge therapies. Financial support for research and development, particularly in antiviral drugs like Ganciclovir, elevates the standard of CMV treatment. Government-led programs also target specific challenges in vulnerable populations, fostering collaborative advancements in the CMV treatment landscape and contributing to broader global public health goals.

Precise and rapid tools like nucleic acid amplification assays and serological tests enable early and accurate CMV detection, driving demand for treatments such as Ganciclovir. Point-of-care testing and sophisticated imaging modalities further enhance diagnostic capabilities, opening new avenues for timely CMV identification. The synergy between advanced diagnostics and treatment modalities reshapes patient care, offering personalized therapeutic approaches. With ongoing technological evolution, the CMV treatment market is set to witness expanded growth opportunities, emphasizing the central role of innovation in enhancing overall patient outcomes.

The shift towards personalized healthcare tailors treatment plans to individual needs, enhancing adherence and addressing CMV infection complexities. Innovative therapies prioritize minimizing side effects and improving outcomes, while patient-friendly administration methods and combination therapies contribute to the evolving CMV treatment landscape. Aligned with the trend of patient-centric care, the market holds promise for advancing and optimizing treatments for cytomegalovirus infections.

Cytomegalovirus Treatment Market Report Highlights

In 2023, the ganciclovir segment accounted for significant market share owing to antiviral efficacy, selective viral targeting, and clinical effectiveness.

In 2023, the stem cell transplantation segment accounted for significant market share owing to elevated risk of CMV reactivation and need for improving overall outcomes.

In 2023, the hospital pharmacy segment held significant revenue share owing to continuous diagnosis and monitoring of patients, and ease of access within healthcare units.

In 2023, North America region dominated the global market due to prevalence and incidence of CMV infections, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including Clinigen Group, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genentech, Inc., Gilead Sciences, Inc., Takeda Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. among others.

Polaris Market Research has segmented the Cytomegalovirus Treatment market report based on drug, application, distribution channel, and region:

Cytomegalovirus Treatment, Drug Outlook (Revenue - USD Million, 2019 - 2032)

  • Ganciclovir
  • Valganciclovir
  • Cidofovir
  • Foscarnet
  • Others

Cytomegalovirus Treatment, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Organ Transplantation
  • Stem Cell Transplantation
  • Congenital CMV Infection
  • Others

Cytomegalovirus Treatment, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Cytomegalovirus Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cytomegalovirus Treatment Market Insights

  • 4.1. Cytomegalovirus Treatment Market - Distribution Channel Snapshot
  • 4.2. Cytomegalovirus Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of cytomegalovirus infections is projected to spur the product demand
      • 4.2.1.2. Rising transplantation activities is expected to drive cytomegalovirus treatment market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of treatment is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cytomegalovirus Treatment Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cytomegalovirus Treatment Market, by Drug

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
  • 5.3. Ganciclovir
    • 5.3.1. Global Cytomegalovirus Treatment Market, by Ganciclovir, by Region, 2019-2032 (USD Million)
  • 5.4. Valganciclovir
    • 5.4.1. Global Cytomegalovirus Treatment Market, by Valganciclovir, by Region, 2019-2032 (USD Million)
  • 5.5. Cidofovir
    • 5.5.1. Global Cytomegalovirus Treatment Market, by Cidofovir, by Region, 2019-2032 (USD Million)
  • 5.6. Foscarnet
    • 5.6.1. Global Cytomegalovirus Treatment Market, by Foscarnet, by Region, 2019-2032 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Cytomegalovirus Treatment Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Cytomegalovirus Treatment Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • 6.3. Organ Transplantation
    • 6.3.1. Global Cytomegalovirus Treatment Market, by Organ Transplantation, by Region, 2019-2032 (USD Million)
  • 6.4. Stem Cell Transplantation
    • 6.4.1. Global Cytomegalovirus Treatment Market, by Stem Cell Transplantation, by Region, 2019-2032 (USD Million)
  • 6.5. Congenital CMV Infection
    • 6.5.1. Global Cytomegalovirus Treatment Market, by Congenital CMV Infection, by Region, 2019-2032 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Cytomegalovirus Treatment Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Cytomegalovirus Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global Cytomegalovirus Treatment Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacy
    • 7.4.1. Global Cytomegalovirus Treatment Market, by Retail Pharmacy, By Region, 2019-2032 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Cytomegalovirus Treatment Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Cytomegalovirus Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cytomegalovirus Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Cytomegalovirus Treatment Market - North America
    • 8.3.1. North America: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
    • 8.3.2. North America: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Cytomegalovirus Treatment Market - U.S.
      • 8.3.4.1. U.S.: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Cytomegalovirus Treatment Market - Canada
      • 8.3.5.1. Canada: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • 8.4. Cytomegalovirus Treatment Market - Europe
    • 8.4.1. Europe: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Cytomegalovirus Treatment Market - UK
      • 8.4.4.1. UK: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Cytomegalovirus Treatment Market - France
      • 8.4.5.1. France: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Cytomegalovirus Treatment Market - Germany
      • 8.4.6.1. Germany: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Cytomegalovirus Treatment Market - Italy
      • 8.4.7.1. Italy: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Cytomegalovirus Treatment Market - Spain
      • 8.4.8.1. Spain: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Cytomegalovirus Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Cytomegalovirus Treatment Market - Russia
      • 8.4.10.1. Russia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • 8.5. Cytomegalovirus Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Cytomegalovirus Treatment Market - China
      • 8.5.4.1. China: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Cytomegalovirus Treatment Market - India
      • 8.5.5.1. India: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Cytomegalovirus Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Cytomegalovirus Treatment Market - Japan
      • 8.5.7.1. Japan: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Cytomegalovirus Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Cytomegalovirus Treatment Market - South Korea
      • 8.5.9.1. South Korea: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • 8.6. Cytomegalovirus Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Cytomegalovirus Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Cytomegalovirus Treatment Market - UAE
      • 8.6.5.1. UAE: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Cytomegalovirus Treatment Market - Israel
      • 8.6.6.1. Israel: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Cytomegalovirus Treatment Market - South Africa
      • 8.6.7.1. South Africa: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
  • 8.7. Cytomegalovirus Treatment Market - Latin America
    • 8.7.1. Latin America: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Cytomegalovirus Treatment Market - Mexico
      • 8.7.4.1. Mexico: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Cytomegalovirus Treatment Market - Brazil
      • 8.7.5.1. Brazil: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Cytomegalovirus Treatment Market - Argentina
      • 8.7.6.1. Argentina: Cytomegalovirus Treatment Market, by Drug, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Cytomegalovirus Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Cytomegalovirus Treatment Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bayer AG
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bristol Myers Squibb
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Chimerix
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Clinigen Group
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Fresenius Kabi
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Genentech, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Gilead Sciences, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. GlaxoSmithKline plc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck & Co., Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Pfizer Inc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Takeda Pharmaceuticals
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceutical Industries Ltd.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Thermo Fisher Scientific
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development